Skip to main content
. 2013 Mar 12;288(17):12270–12282. doi: 10.1074/jbc.M112.411884

FIGURE 3.

FIGURE 3.

Antimicrobial and hemolytic activity of recombinant DEFB114. a, antimicrobial activity of the DEFB114 peptide against E. coli K12D31, S. aureus (CMCC 26003), and C. albicans (SC 5314) (2.0–4.0 × 105 cfu/ml) was measured using cfu assays. b, salt-sensitive antimicrobial activity of DEFB114 (40 μg/ml) was determined in the absence or presence of 150 mm NaCl. c, concentration-dependent hemolytic effects of the recombinant DEFB114 peptide and LL-37 peptide. Treatment with 0.1% Triton X-100 served as a reference for complete hemolysis. The values represent the averages of three independent measurements with duplicate samples. Error bars, S.E.